Cancer Therapeutic Approaches
Cancer cells are known to possess a highly unique metabolic phenotype. Hence development of specific biomarkers in oncology is necessary and they are used to detect the presence of cancer, determine prognosis, and/or assess the viability of treatment. Recent innovations have empowered the examination of numerous potential biomarkers and recharged enthusiasm for growing new biomarkers. Metabolomics allows for a global assessment of a cellular state within the context of the immediate environment, considering genetic regulation, altered kinetic activity of enzymes, and changes in metabolic reactions. Thus, Metabolomics is growing in the field of oncology with particular attention to its application as a biomarker in cancer diagnosis, assessing treatment effects, and in the development of novel therapeutics.
- Role of NMR based metabolomics in Cancer
- Use of metabolomics in Cancer Biomarker discovery
- Applications of metabolomics in Cancer studies
- Future of metabolomics in Oncology
- Role of metabolomics in Precision medicine
Related Conference of Cancer Therapeutic Approaches
18th International Conference on Human Genomics and Genomic Medicine
21th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
16th International Conference on Human Genetics and Genetic Diseases
19th International Conference on Genomics & Pharmacogenomics
Cancer Therapeutic Approaches Conference Speakers
Recommended Sessions
- Analytical Metabolomics
- Cancer Therapeutic Approaches
- Clinical Metabolomics
- Lipidomics
- Metabolic Modelling
- Metabolic Profiling
- Metabolic syndrome
- Metabolomic databases
- Metabolomics & Biotechnology
- Metabolomics & Pharmacology
- Metabolomics in Precision Medicine
- Nutritional Metabolomics
- Plant Metabolomics
- Recent Advancements in Metabolomics
- Therapeutic Metabolomics
- Transcriptomics
- Xenobiotics
Related Journals
Are you interested in
- Artificial Intelligence and Computational Biology in Regenerative Medicine - Stemgen 2026 (France)
- Bioinformatics - HUMAN GENOME 2025 (France)
- Biomaterials and Nanotechnology in Regenerative Medicine - Stemgen 2026 (France)
- Cancer Genomics - HUMAN GENOME 2025 (France)
- Cancer Stem Cells and Oncology - Stemgen 2026 (France)
- Cardiovascular Regeneration - Stemgen 2026 (France)
- Clinical Trials and Translational Stem Cell Research - Stemgen 2026 (France)
- Cognitive Computing - HUMAN GENOME 2025 (France)
- Computational Biology - HUMAN GENOME 2025 (France)
- Drug Detection & Development in Bioinformatics - HUMAN GENOME 2025 (France)
- Emergency Medicine - HUMAN GENOME 2025 (France)
- Epigenetics Biomarkers - HUMAN GENOME 2025 (France)
- Ethical, Legal, and Social Implications in Stem Cell Research - Stemgen 2026 (France)
- Future Trends: Organoids, Bioengineering, and Next-Generation Therapies - Stemgen 2026 (France)
- Gene Editing and CRISPR Technologies - Stemgen 2026 (France)
- Genetically Modified Organisms - HUMAN GENOME 2025 (France)
- Genome Mapping - HUMAN GENOME 2025 (France)
- Genomic Approach to Drug Discovery - HUMAN GENOME 2025 (France)
- Genomic Information in Medicine - HUMAN GENOME 2025 (France)
- Genomic Vaccination - HUMAN GENOME 2025 (France)
- Genomics - HUMAN GENOME 2025 (France)
- Human Gene Therapy - HUMAN GENOME 2025 (France)
- Human Genetics - HUMAN GENOME 2025 (France)
- Induced Pluripotent Stem Cells (iPSCs) and Reprogramming - Stemgen 2026 (France)
- Infectious Diseases - HUMAN GENOME 2025 (France)
- Medicine Genomics - HUMAN GENOME 2025 (France)
- Mesenchymal Stem Cells (MSCs) in Therapy - Stemgen 2026 (France)
- Personalized Medicine - HUMAN GENOME 2025 (France)
- Pharma Genomics & Pharma Informatics - HUMAN GENOME 2025 (France)
- Preimplantation Genetic Diagnosis - HUMAN GENOME 2025 (France)
- Regenerative Dentistry and Craniofacial Applications - Stemgen 2026 (France)
- Regenerative Medicine and Tissue Engineering - Stemgen 2026 (France)
- Stem Cell Banking and Cryopreservation - Stemgen 2026 (France)
- Stem Cell Biology and Cellular Mechanisms - Stemgen 2026 (France)
- Stem Cells in Neurological and Neurodegenerative Disorders - Stemgen 2026 (France)